GEVOGevo, Inc.
What is the market doing?
In a downtrend (−24% vs 200-day). That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
In a downtrend, below its 50- and 200-day averages. Oversold (RSI 26). Price is −24% vs its 200-day average.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How GEVO is trading
Gevo, Inc. is −38% over the past year while the S&P 500 is +18%: 57 points behind the market.
1-year return · S&P 500 +18%
- vs 200-day average
- −24%
vs 200-day average · a clear downtrend
- RSI (14)
- 26
RSI (14) · oversold, sold harder than it has been bought
- Below its 52-week high
- 51%
Below its 52-week high
Details›
- Last close2026-10-08
- $1.36
- 1 monthS&P 500 +1.6%
- −14%
- 1 yearS&P 500 +18%
- −38%
- 5 yearsS&P 500 +86%
- −80%
- vs 50-day average$1.52
- −11%
- 52-week high
- $2.78
- 52-week low
- $1.27
- Annualised volatility
- 90%
| Year | Return |
|---|---|
| 2026 (year to date) | −32% |
| 2025 | −4.3% |
| 2024 | +80% |
| 2023 | −39% |
| 2022 | −56% |
| 2021 | +0.71% |
| 2020 | +84% |
| 2019 | +18% |
| 2018 | −83% |
| 2017 | −83% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 3 of 10 | +9.5% |
| Feb | 10 | 1 of 10 | −17% |
| Mar | 10 | 5 of 10 | +0.01% |
| Apr | 10 | 1 of 10 | −11% |
| May | 10 | 6 of 10 | −2.1% |
| Jun | 10 | 3 of 10 | −12% |
| Jul | 11 | 5 of 11 | +0.02% |
| Aug | 11 | 9 of 11 | +20% |
| Sep | 11 | 5 of 11 | +4.9% |
| Oct | 11 | 5 of 11 | −0.93% |
| Nov | 10 | 2 of 10 | +2.5% |
| Dec | 10 | 4 of 10 | +1.4% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Specialty Chemicals
Ranks #33 of 33 by RyuScore